Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Condition(s):Colorectal CancerLast Updated:May 7, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Colorectal CancerLast Updated:May 7, 2020Completed
Condition(s):Arthritis, Rheumatoid; Crohn Disease; PsoriasisLast Updated:March 18, 2014Completed
Condition(s):Pulmonary Disease, Chronic Obstructive; Infections, BacterialLast Updated:October 12, 2017Completed
Condition(s):Kidney Transplantation; Chronic Kidney FailureLast Updated:August 19, 2016Completed
Condition(s):Peripheral Vascular Diseases; Intermittent ClaudicationLast Updated:August 21, 2008Unknown status
Condition(s):HypercholesterolemiaLast Updated:May 24, 2012Completed
Condition(s):Diabetes Mellitus IILast Updated:September 14, 2010Completed
Condition(s):Coronary ArteriosclerosisLast Updated:November 19, 2010Completed
Condition(s):Heart FailureLast Updated:December 22, 2020Completed
Condition(s):Glycogen Storage Disease Type II; Pompe DiseaseLast Updated:February 1, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.